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Abstract
Background: Chronic systemic inflammation affects brain functionality and may negatively influence the
progression of neurodegenerative disorders. Allergy is a chronic inflammatory disease affecting more than 20%
of the Western population. Little is known regarding the influence of allergy on brain functions. The aim of the
present study was to obtain a global overview of the genes that drive the effects of peripheral inflammation
associated with chronic airway-induced allergy in the brain.
Methods: Airway allergy was induced in C57B/6J mice using ovalbumin as the allergen. Microarray analysis was
performed in the hippocampus and frontal cortex in association with Affymetrix. For the data analysis, principal
component analysis and orthogonal to latent structures discriminant analysis followed by pathway analysis were
used. Quantitative polymerase chain reaction (qPCR) and protein analysis by Western blotting were performed for
the validation of microarray results.
Results: Microarray analysis showed low-grade changes in gene expression in the brain induced by airway-
associated allergy. Changes in expression were observed for genes involved in antigen processing and presentation,
cytokine–cytokine interaction, Toll-like receptor and mitogen-activated protein kinase signaling, as determined by
pathway analysis. We confirmed a reduction of insulin-degrading enzyme at the protein level and a decrease in
insulin receptor phosphorylation in the brains of allergic mice. Other allergy-induced gene expression changes were
confirmed by qPCR, including increased levels of tumor necrosis factor receptor superfamily member 23 and
lipopolysaccharide-binding protein.
Conclusion: Airway-associated allergy induces changes in brain gene expression toward induction of insulin
resistance and inflammatory responses with potential implications for neurodegenerative disorders.
Keywords: Allergy, Insulin-degrading enzyme, Insulin signaling, Neurodegeneration, Neuroinflammation
Background
Systemic inflammation followed by increased levels of brain
proinflammatory cytokines and adaptive behavioral changes
constitute a classic example of immune body-to-brain com-
munication that occurs during acute infections and is
known as “sickness behavior” [1,2]. However, the effects of
chronic peripheral inflammation on the brain have not
been studied extensively. Recent data show that chronic
systemic inflammation is associated with structural brain
changes. White and gray matter atrophy has been observed
in the brains of patients with rheumatoid arthritis [3,4] and
systemic lupus erythematosus [3,4].
It is known that inflammatory processes occur in the
brain in most neurodegenerative disorders. Furthermore,
systemic inflammation has been shown to exacerbate the
ongoing neurodegenerative processes in the brain in
neurodegenerative disorders such as multiple sclerosis,
Parkinson disease, prion disease and cerebral ischemia
[5,6]. Thus, studies of the influence of chronic peripheral
inflammation on the brain are of particular significance,
mainly for brain diseases with underlying neurodegene-
rative pathology.
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Asthma, allergic rhinitis and atopic dermatitis are
among the most commonly encountered diseases with
chronic allergy, known as atopic disorders, often with
onset occurring during childhood or adolescence.
Asthma is a chronic systemic inflammatory disorder of
the airways that affects about 300 million people world-
wide [7]. It is characterized by increased levels of cyto-
kines, infiltration of eosinophils and T-helper type 2
(Th2) cells into the airway submucosa, reversible airway
obstruction, airway hyperresponsiveness and airway re-
modeling [8].
Studies with functional brain magnetic resonance im-
aging in allergic patients have shown increased activity
in the brain, mainly in the anterior insular cortex (AIC)
and anterior cingulate cortex [9]. The increased AIC ac-
tivity was correlated with the degree of inflammation in
the lungs, as well as with disease severity [10]. These
findings indicate that allergy associated with asthma in-
fluences neuronal circuits involved in the processing of
emotional information.
Allergy is characterized by an anti-inflammatory Th2
profile, suggesting that allergic diseases may be associ-
ated with an inflammatory phenotype, which at first
glance may prove beneficial for diseases characterized by
a proinflammatory Th1 profile such as Alzheimer dis-
ease (AD). However, studies in mouse models of allergy
have shown effects of inflammation associated with al-
lergy on brain function. Thus, mice challenged with ov-
albumin (OVA) had increased expression of the
immediate early gene c-fos in different brain regions
[11]. Increased brain levels of cytokines such as interleu-
kin 1 (IL-1) and tumor necrosis factor α (TNF-α)
were found in mice exposed to OVA and particulate
matter [12]. In a recent study, using a chronic airway
allergy model, we showed increased levels of immu-
noglobulins (Igs) in the brains of allergic mice [13].
Furthermore, an epidemiological study showed a posi-
tive correlation between a history of allergic diseases
and risk for dementia [14].
The aim of the present study was to obtain a wider
perspective on gene expression in the brain in response
to allergy, which may lead to the finding of potential





Male mice 12 to 14 weeks old C57B6 (20 to 22 g, n = 16)
were purchased from B&K Universal AB (Sollentuna,
Sweden). The animals were housed four per cage under
controlled conditions of light–dark cycle (12:12 h, lights
on at 06:00 h), temperature (21 ± 1°C), relative humidity
(60% to 65%) and food and water ad libitum. Upon
arrival, the animals were habituated to the environment
for 2 wk before the start of experiments and handled
daily to minimize the stress level after the start of the
chronic allergy protocol. The study was approved by the
Stockholm South local committee on ethics of animal
experiments (S204/10).
Allergen exposure protocol
Both AD and allergy are chronic disorders, and we
have previously validated a chronic model of airway-
induced allergy using a chronic OVA challenge
protocol [13]. Briefly, the mice were sensitized with
a single intraperitoneal (i.p.) injection of a 200-μl
suspension of Al(OH)3 (4 mg/ml) in phosphate-buffered
saline (PBS) containing OVA grade III (0.05 mg/ml;
Sigma-Aldrich, St Louis, MO, USA) (OVA-alum) on
days 0 and 12. The animals were then challenged
daily from day 18 to day 23, and then three times per
week during an additional 5-wk period, by intranasal
instillation of 50 μl of an OVA-alum suspension
containing 2 mg/ml OVA. Control animals received
PBS instead of OVA but otherwise underwent the
same treatment.
The animals were killed 24 h after the last antigen
challenge, and the hippocampus, frontal cortex and
hypothalamus were quickly dissected out, frozen on dry
ice and stored at −70°C until processed for gene expres-
sion and biochemical studies, including microarrays,
RT-PCR and immunoblot analysis.
Microarray technology
Tissue processing
Total RNA was extracted from the left frontal cortex
and hippocampus (approximately 60 mg and 20 mg of
tissue, respectively), using the QIAzol lysis reagent buf-
fer and purified using the RNeasy Mini kit according to
the manufacturer’s instructions (QIAGEN Sciences,
Germantown, MD, USA). The right frontal cortex and
hippocampus were processed for Western blotting as
described below.
Microarray analysis was performed using Affymetrix
whole-transcript expression analysis and the Mouse
Gene 1.1ST profiling array (Affymetrix, Santa Clara, CA,
USA) in association with the Bioinformatics and Expres-
sion Analysis Core Facility (BEA), Karolinska Institutet.
The array plate contains more than 770,000 oligonucleo-
tide probes (25-mere) that cross-examine more than
28,000 genes.
Microarray data analysis
The microarray data processing is summarized into four
main steps: (1) quality control, (2) data preprocessing,
(3) detection of differentially expressed genes (DEGs)
and (4) extraction of biological knowledge [15]. After we
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performed the quality control, we used the Probe Loga-
rithmic Intensity Error (PLIER) algorithm to obtain the
expression level of the gene with a cutoff value of 30
units for the expression above background in all sam-
ples. Genes with expression below the background were
regarded as not expressed and therefore were filtered
out of the analysis. When the proportion of differentially
expressed transcripts in the dataset is small, they tend to
get buried among the nondifferentially expressed
transcripts. There are several alternatives suggested
for filtering of genes [15]. Thus, to reduce the noise,
genes were filtered by fold change using cutoff values
of ±1.10 and ±1.15 for hippocampus and frontal cor-
tex, respectively. This reduced the number of genes
from approximately 14,000 to 1,488 in the hippocam-
pus and 1,459 in the frontal cortex.
Multivariate analysis was performed using the
SIMCA P + software package (UMETRICS AB, Umeå,
Sweden). Principal component analysis (PCA) was used
to provide an overview of the data and to detect pos-
sible outliers. Orthogonal projection to latent structures
discriminant analysis (OPLS-DA) [16] was performed
to detect genes that significantly differed between aller-
gic and control mice. For this purpose, the data were
preprocessed by unit variance scaling and detrending.
Variables with a high level of variance are more likely
to be expressed than those with a low variance. There-
fore, unit variance scaling was selected to scale the data
appropriately. This method uses the inverse standard
deviation (SD) as a scaling weight for each variable.
Detrending improves the interpretability of the data by
subtracting variable averages from the data; thus the
dataset is repositioned around the origin. The score plots
(see Figure 1A through 1D) illustrate the deviation from
the center of the model projected on the components
(to1, to2, to3, …ton). The variables that are important for
the class separation are visualized in the loading plots (see
Figure 2A and 2B).
Figure 1 Allergy induces changes in the brain transcripts as shown by multivariate analysis. Principal compontent analysis (PCA) and
Orthogonal to latent structures discriminant analysis (OPLS-DA) were used to analyze the gene expression in allergic mice (n = 8) and control mice
(n = 8). In the frontal cortex, the number of allergic mice was seven. PCA score plots in the hippocampus (A) (Q2 = 0.415 and R2 = 0.615) and in the
frontal cortex (B) (Q2 = 0.535 and R2 = 0.692) show an overall view of the data. OPLS-DA score plots indicate group separation between allergic and
control mice in the hippocampus (C) (Q2 = 0.488 and R2 = 0.906) and in the frontal cortex (D) (Q2 = 0.590 and R2 = 0.961). H = Hippocampus,
FC = Frontal cortex, C = Control, A = Allergic.
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The number of components in PCA and OPLS-DA
depends on R2 (estimation of fit) and Q2 (estimation of
prediction) values. The Q2 value calculation is based on
sevenfold cross-validation, which means that one-
seventh of the data is omitted for each cross-validation
round.
Jackknifing is an approach used for finding the preci-
sion of an estimate. In PCA and OPLS-DA, jackknifing
uncertainty measures of scores and loadings are calcu-
lated from the set of multiple models generated from
cross-validation [17].
Finally, the significant genes derived from the OPLS-
DA model were analyzed with a web-based gene set
analysis toolkit (WebGestalt (WEB-based GEneSeTAna-
Lysis Toolkit) version 2.0) [18] according to the in-
structions given in the software program. Heat maps
were used to provide an overview of the DEGs in the
respective brain samples. The heat maps were generated
using the R statistical software package (GNU General
Public License; http://www.r-project.org/).
Polymerase chain reaction
To confirm the results obtained by microarray analysis,
gene expression was analyzed by quantitative polymerase
chain reaction (qPCR) using TaqMan probes (Applied
Biosystems, Foster City, CA, USA) for TNF receptor
superfamily 23 (TNFRS23) (ID Mm00656375_m1),
transthyretin (ID Mm004432267_m1) and thyrotropin-
releasing hormone (TRH) (ID Mm 01963590_s1) in the
hippocampus and lipopolysaccharide-binding protein
(LBP) (Mm00493139_m1) in the frontal cortex. The
RNA was reverse-transcribed using the TaqMan High
Capacity cDNA Reverse Transcription kit (Applied
Biosystems). The qPCR was carried out in a total volume
of 20 μl in each well containing 10 μl of TaqMan Gene
Expression Master Mix (Applied Biosystems), 1 μl of
Figure 2 Allergy induces significant changes of gene expression in the mouse brain. Loading plots derived from orthogonal projection to
latent structures (OPLS-DA) illustrate a set of genes that significantly contributed to separating allergic mice from control mice (n = 8) with regard
to the hippocampus (A) (n = 8) and the frontal cortex (B) (n = 7). The confidence level for each gene is estimated by jackknife algorithm.
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TaqMan probes and 2 μl of cDNA corresponding to
10 ng/μl RNA. The reaction was performed in tripli-
cate, and, for quantification of the expression, the
comparative cycle threshold (Ct) method 2ΔΔCt was
used, with ΔΔCt = ((Cttarget gene– Ctendogenouscontrol)aller-
gics – (Cttarget gene – Ctendogenous control)control). β-actin
(Mm 00607939_s1) was used as an endogenous
control.
Western blot analysis
The hippocampus, frontal cortex and hypothalamus
were homogenized by sonication in homogenization
buffer consisting of 20 mM Tris•HCl, pH 6.8,
containing 137 mM NaCl and 2 mM ethyl-
enediaminetetraacetic acid, 2% Nonidet P-40 and 2%
Triton X-100 (Sigma-Aldrich, St Louis, MO, USA),
supplemented with a protease inhibitor cocktail
(Sigma-Aldrich), phosphatase inhibitors (Halt protease
inhibitor cocktail; Pierce Biotechnology, Rockford, IL,
USA) and 2 nM okadaic acid (Sigma-Aldrich). The
brain tissue homogenates were centrifuged at 4°C for
20 min at 20,000 × g, and the supernatants were col-
lected and rapidly frozen. The protein content of the
supernatants was determined using a bicinchoninic
acid kit (Sigma-Aldrich).
Samples containing equal amounts of proteins (20 to
40 μg) were added to sodium dodecyl sulfate (SDS) in
2 × sample loading buffer (50 mM Tris, pH 6.8,
containing 10% glycerol, 0.1% bromophenol blue,
2% SDS and 5% β-mercaptoethanol; Sigma-Aldrich),
electrophoresed in 10% SDS polyacrylamide gel and
transferred to a 45-μm nitrocellulose membrane (Bio-
Rad Laboratories, Hercules, CA, USA). After blocking
with 5% nonfat milk in TBS-T (20 mM Tris•HCl, pH
7.4, 137 mM NaCl and 0.1% Tween 20) for 30 min at
room temperature, the membrane was incubated over-
night at 4°C with primary antibodies (1:1,000 insulin-
degrading enzyme (IDE), Abcam, Cambridge, MA, USA;
1:1,000 phosphorylated insulin receptor (p-IR) and
1:1,000 total insulin receptor (t-IR) cell signaling, re-
spectively; 1:2,000 β-actin, cell signaling suggested con-
centration by manufacturer 1:1000) in blocking solution.
The blots were washed with TBS-T for 30 min and incu-
bated with the appropriate secondary antibodies for 2 h
at room temperature. After being rinsed in TBS-T for 30
min, the blots were incubated for 5 min with Amersham
ECL Prime Western Blotting Detection Reagent (GE
Healthcare Life Sciences, Piscataway, NJ, USA), and the
chemiluminescence was detected using a charge-coupled
device camera (LAS-3000; Fujifilm Life Science,
Düsseldorf, Germany). Quantification of signals was
performed using Multi Gauge (version 3.0) software
(Fuji Photo Film Co, Tokyo, Japan). The protein levels
were normalized to β-actin levels, which were used as a
housekeeping protein.
Statistical analysis
The statistical analysis for the validation data was
performed using SPSS version 20 statistical software
(SPSS, Inc, Chicago, IL, USA) with Student’s t-test for
normally distributed data.
Results
Differentially expressed gene analysis
Increased brain levels of IgG and IgE were found in al-
lergic mice, a finding which is in agreement with our
previous data [13]. Microarray analysis revealed changes
in brain gene expression in mice with chronic airway al-
lergy, even though most of the genes analyzed were
expressed in both allergic and control animals and were
not influenced by the allergy. Ten percent of the genes
found to be up- or down-regulated by allergy were se-
lected by the means of foldchange. The result of this cal-
culation was 1,488 and 1,459 genes in the hippocampus
and frontal cortex, respectively.
PCA was performed for overall analysis to detect pos-
sible outliers in the data. Each mouse has its unique ex-
pression profile in the variable space, and therefore data
that show similar expression profiles are grouped together
in the PCA score plot. The results show that the allergic
mice differed from control mice, despite some degree of
overlap between the groups (Figure 1A and 1B). However,
no outliers were detected.
To identify genes that contributed to the differences
between allergic and control mice, the data were ana-
lyzed by OPLS-DA. It was thus possible to depict a
group separation in mice as indicated in the score plots
(Figure 1C and 1D). The predictive component in the
score plots (t1) indicates that gene expression in allergic
mice differs from that in control mice. In addition, the
allergic mice cluster shows less variation than control
mice in the orthogonal component (to1), possibly
reflecting their common allergic phenotype. OPLS-DA
identified 257 and 856 significant DEGs in the hippo-
campus and frontal cortex, respectively. All of the DEGs
that contributed to discrimination between the allergic
and control mice in each brain region are presented in
Additional file 1: Table 1 and Table 2. Some of those
genes are presented in loading plots (Figure 2A and 2B).
The datasets were alternatively analyzed using univari-
ate statistics. To provide an overview of the altered
genes in respective regions, a subset of major DEGs
based on P values and fold changes was selected, log2-
transformed and visualized as heat maps using the R
statistical software package (Figure 3A and 3B). Interes-
tingly, the sample HA2 was identified as an outlier using
both statistical approaches (Figures 1C and 3A).
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Functional pathways modified by allergy
Bioinformatics approaches such as pathway analysis pro-
vide a tool for interpretation of large gene datasets by
putting them in the context of biological processes,
pathways and networks. To understand which pathways
were altered in the mouse brain due to allergy, we used
the WebGestalt version 2.0 algorithm to identify signifi-
cant functional enrichment in DEGs. The DEGs detected
by OPLS-DA were selected for pathway analysis.
The analysis of KEGG (Kyoto Encyclopedia of Genes
and Genomes) pathways in the hippocampus and frontal
cortex showed significant enrichment for genes involved
in several pathways, as depicted in Figure 4A and 4B.
The majority of the indicated pathways were involved in
inflammatory responses, such as antigen processing and
presentation, Toll-like receptor (TLR) signaling, comple-
ment and coagulation cascade, JAK-STAT (Janus kinase
and signal transducer and activator of transcription) sig-
naling and cytokine–cytokine interactions. The genes
that were altered by allergy in some of the pathways are
shown in Additional file 2: Table 3 and Table 4 for
hippocampus and frontal cortex, respectively.
Validation of microarrays
The microarray data showed that allergy was associated
with a reduction in IDE, which mediates cleavage of in-
sulin and amyloid-β (Aβ), important proteins in diabetes
mellitus and AD, respectively. Western blot analysis of
the protein levels showed a significant decrease in IDE
in both the hippocampus (Figure 5A) [95% confidence
interval (CI) 0.64-1.57; P < 0.001] and the frontal cortex
(Figure 5B) [95% CI 1.19-2.82; P < 0.001] of allergic mice
compared to controls. Since insulin signaling in the
hypothalamus plays an important role in the regulation
of glucose metabolism, the hypothalamic IDE levels were
measured. The IDE levels were significantly reduced in
the hypothalamus from allergic mice [95% CI 0.59-0.66;
P < 0.05] (Figure 5C). As insulin is a major substrate for
IDE, we further analyzed whether changes in IDE could
have a functional impact on insulin signaling. The levels
and phosphorylation status of IRs were analyzed by im-
munoblotting. t-IR levels were similar in allergic and
control mice; however, allergy was associated with a sig-
nificant decrease in the levels of p-IR [95% CI 0.01- 0.31;
P < 0.05] in the hippocampus (Figure 6) but not in the
frontal cortex and hypothalamus, although the data showed
a trend similar to that in the hippocampus (data not
shown). We also analyzed the expression of transthyretin
and TRH by qPCR; however, we found no changes between
the groups (data not shown), as indicated by the microarray
data.
We have further validated other significant changes
provided by the microarray analysis with qPCR for
TNFRS23 in the hippocampus (Figure 7A) and LBP in
the frontal cortex (Figure 7B). The results were in line
with the microarray data. Thus, the levels of TNFRS23
were increased in the hippocampus of allergic mice [95%
CI −0.82- −0.31; P < 0.001] and LBP levels were increased
in the frontal cortex [95% CI −0.49 - −0.04; P < 0.05].
Discussion
The previously reported association between allergic dis-
eases and dementia [14], as well as the inflammatory
changes induced by allergy in the brain [12,13], repre-
sents a basis for further studies on the effects of allergy
on the brain. We have analyzed gene expression in
mouse brains and found that allergy led to changes in
the genes and/or proteins involved in the insulin-
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Figure 3 Allergy induces changes of gene expression in the mouse brain as shown by cluster analysis. A subset of highly differentially
expressed genes (DEGs) was selected from the hippocampus (A) and the frontal cortex (B), and the heat maps were generated from log2-transformed
data using the R statistical software package. H = Hippocampus, FC = Frontal cortex, C = Control, A = Allergic.
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Figure 4 Pathway analysis of allergy induced differentially expressed genes in the brain. KEGG (Kyoto Encyclopedia of Genes and
Genomes) pathway analysis was performed on significantly altered genes between allergic mice and control mice as analysed with orthogonal
projection to latent structures discriminant analysis (OPLS-DA). A subset of the significantly enriched pathways is depicted in hippocampus





Figure 5 Allergy decreases the levels of insulin-degrading enzyme (IDE) in the mouse brain. Western blot analysis showed a decrease in
IDE levels in the hippocampus (A), frontal cortex (B) and hypothalamus of allergic mice compared to controls (C). The data were analyzed using
Student’s t-test. The boxplot indicates the first two quartiles with the median, and the whiskers indicate the third and fourth quartiles (n = 8 mice
per group). Only six control mice were used for the hypothalamus because two samples were lost during sonication. The images below the
graph indicate the immunoblotting of IDE. Asterisk, p < 0.05, triple asterisk p < 0.001.
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Inflammation has been shown to play an important
role in the development of neurodegenerative diseases
[5]. The present microarray data show that several in-
flammatory pathways were altered in the brain. Further-
more, signaling pathways found to be modified in the
allergic mouse brain, including neurotrophin signaling,
TLR-signaling, complement and coagulation cascades,
and cytokine–cytokine interactions, have been pointed
out in AD [19]. In view of these findings, it may be as-
sumed that allergy may render the brain more suscep-
tible to challenges later in life.
The mRNA expression for TNFRS23 and LBP was in-
creased in the allergic brain, consistent with the results
obtained from the microarrays. TNFR23 is a decoy re-
ceptor with unknown function. Clark et al. reported its
involvement in parental imprinting [20], and a subse-
quent study showed an immunomodulatory role by in-
hibition of T-cell proliferation [21]. In view of these
findings, the increase in TNFR23 mRNA upon allergy
may be interpreted as a means to modulate an inflam-
matory response induced by the allergy. LBP is an
acute-phase protein mainly produced in the liver. In
brain, LBP expression has been detected in the hippo-
campus and choroid plexus [22]. Together with CD14,
LBP is involved in enhancing the strength of LPS-
induced responses to type I interferons (IFNs) [23]. In
the present study, the transcripts of several type I IFNs
were found to be increased in the frontal cortex, indi-
cating that TLR4-signaling may be altered in the aller-
gic brains.
The difference in gene expression was moderate with
regard to foldchange in allergic mice compared to con-
trol mice in both the hippocampus and the frontal cor-
tex. The use of one time point for the analysis may be a
limitation in that early transient changes in gene expres-
sion may not be found. This is supported by a previous
report based on a chronic allergy model in which the
gene expression in the lungs was not only associated
with low-grade changes but also characterized by a re-
turn to baseline levels of a large number of genes [24].
However, it is likely that chronic conditions may be as-
sociated with low-grade changes in contrast to acute
conditions and that accumulation of the effects of these
gradual and/or transitory changes may have functional
consequences over time.
Our data show that allergy was associated with a sig-
nificant reduction in the IDE levels in the brain. IDE
*
Figure 6 Allergy decreases the insulin receptor phosphorylation
in the mouse brain. The levels of phosphorylated insulin receptor
(p-IR) were significantly reduced in the hippocampus of allergic mice
compared to controls. The data were analyzed using Student’s t-test.
The boxplot shows the first two quartiles with the median, and the
whiskers indicate the third and fourth quartiles (n = 16 for the allergic
group and n = 17 for the control group). t-IR, total insulin receptor. The
images below the graph show the immunoblotting of p-IR. Asterisk,
p < 0.05, ° indicates outliers.
A B
*** *
Figure 7 Confirmation of allergy induced changes in gene expression by quantitative PCR. RNA was reverse-transcribed and probed for
the tumor necrosis factor receptor superfamily member 23 (TNFRS23) in the hippocampus (A) and lipopolysaccharide-binding protein (LPB) in
the frontal cortex (B). The qPCR results are in accord with the data obtained from microarray analysis. The data were analyzed using Student’s
t-test. The boxplot indicates the first two quartiles with the median, and the whiskers indicate the third and fourth quartiles (n = 8 mice per
group). Asterisk, p< 0.05, triple asterisk, p< 0.001. AU, arbitrary units.
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plays a key role in the degradation of insulin and Aβ,
classic hallmarks of diabetes mellitus and AD, respect-
ively. Macrophage inflammatory protein 1, a C-C motif
chemokine with proinflammatory properties, has been
identified as a substrate for IDE [25], raising the possibil-
ity that IDE may play a role in suppressing inflammatory
responses. A reduction of IDE in response to allergy
may thus result in increased levels of C-C motif–
containing chemokines. Notably, reduced IDE levels
have been found in the brains of AD patients and in
mouse models of AD [26], thus rendering a potential
link between allergy, insulin-related deficits and AD.
IDE is widely expressed in the brain, especially in neu-
rons; but other cells, including oligodendrocytes, micro-
glia and astrocytes, are putative sources [27-29]. Analysis
of the regional distribution pattern of IDE in human
brain showed intense staining in brain regions known
for their high levels of insulin and insulin receptors, that
is, the cerebral cortex and the hippocampus [30]. The
observation of reduced IDE levels in the brains of aller-
gic mice motivated further studies on the effects in insu-
lin receptor signaling. In agreement with data from the
microarray analysis, there was no significant difference
in insulin receptor protein levels between allergic and
control mice. Phosphorylation of the insulin receptor is
necessary for signaling, and we observed a decreased
phosphorylation of the insulin receptor in the hippocam-
pus. The phosphorylation of the insulin receptor in the
hypothalamus did not reach significance, presumably
due to the small numbers of animals investigated. The
observed decrease in levels of the phosphorylated form
of this receptor upon allergy suggests an allergy-induced
inhibition of insulin signaling in the brain. Insulin signal-
ing in the brain plays an important role in the regulation
of peripheral fat and glucose metabolism [31], and defi-
cits in brain insulin signaling have been linked to devel-
opment of diabetes type 2 (DT2) and obesity [32]. Mice
lacking neuronal insulin receptors were found to be
obese and showed increased peripheral insulin resistance
and hypertriglyceridemia [33]. Previously, it was shown
that chronic exposure to TNF-α decreased insulin recep-
tor phosphorylation in adipocytes [34] and that in-
creased levels of TNF-α, IL-6 and IL-1β are linked to
systemic inflammation and accompany insulin resistance
[35]. In view of these studies and the present findings, it
would be interesting to study whether mice with allergy-
associated inflammation develop insulin resistance.
In addition to its peripheral actions, insulin has been
shown to enhance memory formation [36], presumably
by binding to receptors in the hippocampus and adja-
cent limbic structures that are important for memory.
Impaired insulin signaling has been implicated in AD
[32], thus underscoring a shared dysregulated pathway
between a cognitive disease and a metabolic disorder.
Asthma is associated with DT2 and obesity [37,38], both
of which are metabolic disorders with an underlying sys-
temic inflammatory profile. Together with our data, this
suggests that systemic inflammation associated with al-
lergy may modify insulin signaling in the brain, which
could have consequences for brain function and the
pathophysiology of some neurodegenerative disorders.
Analysis at the gene level is advantageous in providing
an overview of the transcription in a given biological sys-
tem, but is insufficient by itself to describe posttranscrip-
tional biological events, including mechanisms controlling
the protein translational rate, the half-life of mRNA or
protein and the intracellular localization and posttransla-
tional modification of the proteins [39].
In summary, our results show that airway inflammation
associated with allergy influences the brain with regard to
proteins involved in insulin signaling and genes involved
in inflammation, as well as other functional pathways.
These results may have implications for further under-
standing the mechanisms behind an association of chronic
inflammation such as allergy with endocrine disorders
such as DT2 and obesity and neurodegenerative disorders
such as AD, all of which share an ongoing inflammatory
component as a common denominator.
Additional files
Additional file 1: Table 1. Allergy-induced differentially expressed
genes (DEGs) in the hippocampus. A total number of 1,488 hippocampal
genes were included in orthogonal projection to latent structure
discriminant analysis (OPLS-DA) to detect DEGs in allergic mice compared
to controls. All 257 genes that were found to significantly contribute to
group separation are listed. Table 2. Allergy-induced differentially
expressed genes (DEGs) in the frontal cortex. A total number of 1,459
frontal cortical genes were subjected to orthogonal projection to latent
structure discriminant analysis (OPLS-DA) to detect DEGs in allergic mice
compared to controls. All 856 genes that were found to significantly
contribute to group separation are listed.
Additional file 2: Table 3. Genes involved in enrichment of KEGGa
pathways in the hippocampus. Significant differentially expressed genes
(DEGs) between allergic mice compared to controls were detected by
orthogonal projection to latent structures discriminant analysis (OPLS-DA)
and subsequently subjected to pathway analysis. Genes that were
involved in significantly enriching the indicated KEGG pathways in the
hippocampus are shown in the list. aMAPK, mitogen activated protein
kinase. Table 4. Genes involved in enrichment of KEGGa pathways in the
frontal cortex. Significant differentially expressed genes (DEGs) between
allergic mice compared to controls were detected by orthogonal
projection to latent structures discriminant analysis (OPLS-DA) and
subsequently subjected to pathway analysis. Genes that were involved in
significantly enriching the indicated KEGG pathways in the frontal cortex
are shown in the list. aKyoto Encyclopedia of Genes and Genomes.
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